ici 118551 has been researched along with methoxamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedi, GS | 1 |
| Brinker, MR; Cook, SD; Hyman, AL; Lippton, HL | 1 |
| Elliott, J; Soydan, J | 1 |
| Pfaffendorf, M; van Zwieten, PA; Winkler Prins, EA; Zwaveling, J | 1 |
| Bennett, D; Moss, R; Tighe, D | 1 |
| Baer, PG; Bennett, T; Brown, KK; Gardiner, SM; Nunez, DJ | 1 |
6 other study(ies) available for ici 118551 and methoxamine
| Article | Year |
|---|---|
The effect of adrenergic agonists and antagonists on cysteine-proteinase inhibitor (cystatin) in rat saliva.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Blotting, Western; Cysteine Proteinase Inhibitors; Dobutamine; Electrophoresis, Polyacrylamide Gel; Female; Isoproterenol; Methamphetamine; Methoxamine; Metoprolol; Norepinephrine; Propanolamines; Propranolol; Radioimmunoassay; Rats; Rats, Inbred Strains; Salivary Proteins and Peptides; Terbutaline | 1991 |
Pharmacological regulation of the circulation of bone.
Topics: Acetylcholine; Animals; Atropine; Bone and Bones; Bucladesine; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Isoproterenol; Methoxamine; Nitroglycerin; Peptides; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Receptors, Drug; Regional Blood Flow; Tibia; Vasoconstrictor Agents; Vasodilator Agents | 1990 |
Characterisation of beta-adrenoceptors in equine digital veins: implications of the modes of vasodilatory action of isoxsuprine.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Azepines; Blood Vessels; Dose-Response Relationship, Drug; Fenoterol; Horses; Isoproterenol; Isoxsuprine; Methoxamine; Nifedipine; Norepinephrine; Phenylephrine; Propanolamines; Receptors, Adrenergic, beta; Vasoconstriction; Vasodilation; Veins | 1995 |
The influence of hyperthyroidism on beta-adrenoceptor-mediated relaxation of isolated small mesenteric arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Colforsin; Dose-Response Relationship, Drug; Hyperthyroidism; Imidazoles; Isoproterenol; Male; Mesenteric Arteries; Methoxamine; Muscle Contraction; Muscle Relaxation; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Thyroxine; Vascular Resistance; Vasoconstrictor Agents | 1996 |
Porcine hepatic response to sepsis and its amplification by an adrenergic receptor alpha1 agonist and a beta2 antagonist.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Heart; Hemodynamics; Liver; Methoxamine; Multiple Organ Failure; Propanolamines; Sepsis; Swine | 1998 |
Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats.
Topics: Acetylcholine; Animals; Hemodynamics; Indans; Male; Methoxamine; Naphthyridines; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxazoles; Phentolamine; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tyrosine | 2004 |